Article
Point-of-care tests could help the local community pharmacy become a neighborhood health center.
I don’t typically comment on a specific product launch because I don’t want it to seem like I’m favoring a particular manufacturer, and I’m often not familiar with the science behind the device.
Concerning the recent availability of Roche’s speedy cobas Strep A test, however, I want to offer same observations on how such a test could help the local community pharmacy become a neighborhood health center.
This example of a point-of-care test could enable the pharmacist to provide a diagnosis and suggest treatment. Although some might argue this is not the pharmacist’s role, I think it can and should be in the future.
We have a growing shortage of primary care providers, so why not let the trained pharmacist enter this arena? Point-of-care testing can take the guesswork out of the diagnosis equation. Under treatment guidelines, it could allow the pharmacists to initiate first-line therapy.
This seems like a win-win situation for everyone involved, as the patient receives quick, quality service at less cost.
Am I too far off base for pharmacy's future?
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk